Antioxidants May Be Harmful in Patients With Melanoma

Share this content:

the ONA take:

Antioxidants may double the rate of metastasis in malignant melanoma, a study published in the journal Science Translational Medicine has shown.

Because melanoma cells are especially sensitive to free radicals, which can be neutralized by antioxidants, and the cells can be exposed to antioxidants through means other than diet, researchers from Sahlgrenska Academy at the University of Gothenburg in Sweden sought to evaluate the effect of antioxidants on cell cultures from patients with malignant melanoma.

The researchers found that although antioxidants protect healthy cells from free radicals that can potentially transform them into malignancies, they may also protect the tumor.

Results showed that the antioxidant enhanced the tumor’s ability to metastasize; however, the primary melanoma tumor was unaffected.

“Previous research as Sahlgrenska Academy has indicated that cancer patients are particularly prone to take supplements containing antioxidants.

Our current research combined with information from large clinical trials with antioxidants suggest that people who have been recently diagnosed with cancer should avoid supplements,” the authors conclude.

Antioxidants may not fight cancer, according to research
Antioxidants may double the rate of metastasis in malignant melanoma.
When we think of the word "antioxidant," we often associate it with health and vitality. Fruits and vegetables "rich in antioxidants" are a good thing after all, right? A new study conducted in mice, however, suggests that antioxidants can actually double the rate of melanoma metastasis.
READ FULL ARTICLE From Medical News Today
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs